It is not clear what would become of the federal government’s health care enforcement efforts without the False Claims Act’s qui tam program.
The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...
(Bloomberg) -- GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw ...
NEW YORK, NY / ACCESS Newswire / March 9, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws ...
The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...
New York, New York--(Newsfile Corp. - March 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) ...
Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...
Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid ...
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the ...
GSK’s Rockville location, which opened in Dec. 2016, was GSK’s first U.S. center dedicated to vaccine research and development, and hosts 350 employees, according to the company’s website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results